BALPHARMA.BOBALPHARMA.BOBSE
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank36
3Y CAGR-14.0%
Studio
Year-over-Year Change

Price-to-earnings ratio

3Y CAGR
-14.0%/yr
vs -8.9%/yr prior
Acceleration
-5.1pp
Decelerating
Percentile
P36
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
202518.16-7.3%
202419.60-52.1%
202340.91+43.5%
202228.50+77.3%
202116.08+534.5%
2020-3.70-113.9%
201926.56-35.8%
201841.36-33.5%
201762.19-32.8%
201692.55-